Amedica Announces Expansion Of Executive Team (press release)
Amedica Corporation, a spinal and reconstructive medical device manufacturer, today announced several new additions to its executive management team to help guide the company's efforts as Amedica shifts the standard of care for interbody fusion devices toward proprietary Silicon Nitride (Si3N4) ceramic. Four strategic appointments, including a Senior Vice President of Market Development, Vice President of Marketing, a Senior Vice President of Sales, and a Chief Legal and Compliance Officer, have been added to the executive team to help execute on the company's business objectives.
Amedica is focused on advancing medical applications of its proprietary Silicon Nitride ceramic. In November 2007, Amedica secured clearance from the U.S. Food and Drug Administration to manufacture and market Silicon Nitride-based interbody fusion devices. The resulting Valeo® product line was launched in 2008 and has since been adopted by physicians across the country as the premier interbody fusion device. In September 2012, Amedica announced the expansion of biomaterial claims for its FDA 510(k) cleared Valeo Interbody Fusion Devices. In r...
